inderal
astrazeneca limited - propranolol hydrochloride 160mg - film coated tablet - 160 mg - active: propranolol hydrochloride 160mg excipient: calcium carbonate carmellose calcium cochineal gelatin glycerol hypromellose magnesium stearate titanium dioxide
inderal tablet 10mg
astrazeneca sdn. bhd. - propranolol hydrochloride -
inderal tablet 40mg
astrazeneca sdn. bhd. - propranolol hydrochloride -
inderal tablet 10mg
dksh malaysia sdn bhd - propranolol hydrochloride -
inderal tablet 40mg
dksh malaysia sdn bhd - propranolol hydrochloride -
ulcidine tablet
valeant canada lp / valeant canada s.e.c. - famotidine - tablet - 40mg - famotidine 40mg - histamine h2-antagonists
ergotamine tartrate and caffeine tablet, film coated
cintex services, llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - ergotamine tartrate 1 mg - ergotamine tartrate and caffeine tablets are indicated as therapy to abort or prevent vascular headache; e.g., migraine, migraine variants or so-called “histaminic cephalalgia.” coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine tartrate and caffeine tablets was coadministered, at least one resulting in death. because of the increased risk of ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). ergotamine tartrate and caffeine tablets may cau
ergotamine tartrate and caffeine tablet, film coated
mikart, llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - ergotamine tartrate 1 mg - ergotamine tartrate and caffeine tablets are indicated as therapy to abort or prevent vascular headache; e.g., migraine, migraine variants or so-called “histaminic cephalalgia.” coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine tartrate and caffeine tablets was coadministered, at least one resulting in death. because of the increased risk of ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). er
propranolol 40mg tablets
crescent pharma ltd - propranolol hydrochloride - oral tablet - 40mg
inderal
astrazeneca pty ltd - propranolol hydrochloride -